Who is the CEO of Hexima Limited?

The CEO of Hexima Limited is Geoffrey Paul Kempler.

What industry does Hexima Limited belong to?

Hexima Limited operates in the Biotechnology industry within the Healthcare sector.

Where is Hexima Limited headquartered?

Hexima Limited is headquartered at Corporate One, Preston, VIC, 3072, AU.

What is the IPO date of Hexima Limited?

Hexima Limited went public on November 30, 2020.

How many employees does Hexima Limited have?

The total number of employees at Hexima Limited is disclosed periodically in the company's annual financial reports.

Hexima Limited

HXL.AX•ASX

Healthcare

Biotechnology

A$0.01

A$0.00(0.00%)

Hexima Limited (HXL.AX) Company Profile & Overview

Explore Hexima Limited’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Hexima Limited (HXL.AX) Company Profile & Overview

Hexima Limited, a biotechnology company, engages in the research and development of plant-derived proteins and peptides for applications as human therapeutics. The company's lead drug candidate is the plant defensin, pezadeftide, which is in phase IIb clinical trials for the treatment of fungal toenail infections in Australia and New Zealand. Hexima Limited was incorporated in 1997 and is based in Preston, Australia.

SectorHealthcare

IndustryBiotechnology

CEOGeoffrey Paul Kempler

Contact Information

https://www.hexima.com.au

61 3 9479 1210

Corporate One, Preston, VIC, 3072

Company Facts

IPO DateNov 30, 2020

CountryAU

Frequently Asked Questions

;